Skip to Content

NVR D3 (Afinitor disperz 3 mg)

Generic Name: everolimus

Pill imprint NVR D3 has been identified as Afinitor disperz 3 mg.

Afinitor Disperz is used in the treatment of neuroendocrine carcinoma; brain tumor and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor Disperz 3 mg is not a controlled substance under the Controlled Substance Act (CSA).

Afinitor disperz
Generic Name:
everolimus
Imprint:
NVR D3
Strength:
3 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals Corporation
National Drug Code (NDC):
00078-0627
Inactive Ingredients:
butylated hydroxytoluene
magnesium stearate
lactose monohydrate
hypromelloses
crospovidone
mannitol
microcrystalline cellulose
silicon dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide